Source: New feed
Swiss biotech NLS Pharma's ADHD drug succeeds in mid-stage study
Swiss biotech NLS Pharma AG said on Wednesday mid-stage trial data showed that its drug to treat attention deficit hyperactivity disorder (ADHD) greatly reduced symptoms in adults, paving the way for a late-stage trial. ADHD is a chronic condition ...
and more »
[at Investor's Business Daily] - Tech giants Apple (AAPL), Alphabet (GOOGL) and Amazon (AMZN) ...…